China SXT Return On Equity vs. Price To Earning

SXTC Stock  USD 1.08  0.07  6.09%   
Based on China SXT's profitability indicators, China SXT Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in June. Profitability indicators assess China SXT's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.46)
Current Value
(0.44)
Quarterly Volatility
0.57628383
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, China SXT's Sales General And Administrative To Revenue is projected to increase slightly based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 360.99, whereas Price To Sales Ratio is forecasted to decline to 4.08. At present, China SXT's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Change To Netincome is expected to grow to about 4.5 M, whereas Accumulated Other Comprehensive Income is projected to grow to (215.8 K).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.240.25
Sufficiently Down
Slightly volatile
For China SXT profitability analysis, we use financial ratios and fundamental drivers that measure the ability of China SXT to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well China SXT Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between China SXT's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of China SXT Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Is China SXT's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.426
Earnings Share
(26.95)
Revenue Per Share
3.65
Quarterly Revenue Growth
(0.22)
Return On Assets
(0.46)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

China SXT Pharmaceuticals Price To Earning vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining China SXT's current stock value. Our valuation model uses many indicators to compare China SXT value to that of its competitors to determine the firm's financial worth.
China SXT Pharmaceuticals is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in price to earning category among related companies . At present, China SXT's Return On Equity is projected to slightly decrease based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value China SXT by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for China SXT's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the China SXT's earnings, one of the primary drivers of an investment's value.

China Price To Earning vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

China SXT

Return On Equity

 = 

Net Income

Total Equity

 = 
-1.42
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

China SXT

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
5.73 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

China Price To Earning Comparison

China SXT is currently under evaluation in price to earning category among related companies.

China SXT Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in China SXT, profitability is also one of the essential criteria for including it into their portfolios because, without profit, China SXT will eventually generate negative long term returns. The profitability progress is the general direction of China SXT's change in net profit over the period of time. It can combine multiple indicators of China SXT, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-227.2 K-215.8 K
Interest Income4.7 K4.4 K
Operating Income-5 M-4.8 M
Net Loss-5.3 M-5.1 M
Income Before Tax-5.3 M-5.1 M
Total Other Income Expense Net134.6 K141.3 K
Net Loss-5.2 M-4.9 M
Net Loss-5.3 M-5.1 M
Income Tax Expense548.3 K575.7 K
Net Interest Income-429.1 K-450.6 K
Change To Netincome4.3 M4.5 M
Net Loss(6.56)(6.89)
Income Quality 0.02  0.01 
Net Income Per E B T 0.95  0.71 

China Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on China SXT. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of China SXT position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the China SXT's important profitability drivers and their relationship over time.

Use China SXT in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China SXT position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China SXT will appreciate offsetting losses from the drop in the long position's value.

China SXT Pair Trading

China SXT Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to China SXT could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace China SXT when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back China SXT - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling China SXT Pharmaceuticals to buy it.
The correlation of China SXT is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as China SXT moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if China SXT Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for China SXT can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your China SXT position

In addition to having China SXT in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Basic Utilities Thematic Idea Now

Basic Utilities
Basic Utilities Theme
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
Check out World Market Map.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for China Stock analysis

When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stocks Directory
Find actively traded stocks across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
To fully project China SXT's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of China SXT Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include China SXT's income statement, its balance sheet, and the statement of cash flows.
Potential China SXT investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although China SXT investors may work on each financial statement separately, they are all related. The changes in China SXT's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on China SXT's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.